Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

179 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A comparison of two treatment regimens of ceftriaxone in late Lyme disease.
Dattwyler RJ, Wormser GP, Rush TJ, Finkel MF, Schoen RT, Grunwaldt E, Franklin M, Hilton E, Bryant GL, Agger WA, Maladorno D. Dattwyler RJ, et al. Among authors: hilton e. Wien Klin Wochenschr. 2005 Jun;117(11-12):393-7. doi: 10.1007/s00508-005-0361-8. Wien Klin Wochenschr. 2005. PMID: 16053194 Clinical Trial.
A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium.
Sigal LH, Zahradnik JM, Lavin P, Patella SJ, Bryant G, Haselby R, Hilton E, Kunkel M, Adler-Klein D, Doherty T, Evans J, Molloy PJ, Seidner AL, Sabetta JR, Simon HJ, Klempner MS, Mays J, Marks D, Malawista SE. Sigal LH, et al. Among authors: hilton e. N Engl J Med. 1998 Jul 23;339(4):216-22. doi: 10.1056/NEJM199807233390402. N Engl J Med. 1998. PMID: 9673299 Clinical Trial.
179 results